Biotech entity
Every one of those 3 sits in a single category, pharma. The 101-day window averages about 0.2 stories each week. The busiest single day carried 2. Of the tracked stories, 1 of 3 also mention Australia, the most common co-covered peer.
Last mentioned: Jul 18, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 3 sits in a single category, pharma. The 101-day window averages about 0.2 stories each week. The busiest single day carried 2. Of the tracked stories, 1 of 3 also mention Australia, the most common co-covered peer. At 7.7, the average consequence score sits above the same-window beat average of 6.2. They are better corroborated than the beat average, carrying 4 original sources each against 3.4 for the same window. Strait of Hormuz appears in 3 tracked Biotech stories published from March 7, 2026 through June 15, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 300 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Strait of Hormuz. Shared-story counts are live from our verified record — not editorial picks.
Biotech and pharma sectors face supply chain risks from the West Asia situation, but the Indian government claims a multi-pronged strategy will prevent shortages. While concrete fertilizer diversification details are given, pharma-specific mitigation remains less specific, though close monitoring is emphasized.
Source: asiabulletin.com · milwaukeesun.com
Escalating geopolitical tensions involving Iran have triggered a high-alert status across the global pharmaceutical industry as critical supply routes face potential closure. The conflict threatens the transit of active pharmaceutical ingredients (APIs) and medical electronics, forcing manufacturers to brace for significant delays and rising costs.
The escalating conflict between the U.S., Israel, and Iran has paralyzed the Strait of Hormuz, causing a surge in energy prices and disrupting critical trade routes. For the pharmaceutical industry, this geopolitical instability threatens the global supply of raw materials and increases the cost of temperature-controlled logistics.
Strait of Hormuz is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
